The report offers detailed coverage of Thebaine industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Thebaine by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
Thebaine, also known as paramorphine, is a white, crystalline, slightly water-soluble (in pure form after a synthesis), poisonous alkaloid. Thebaine is not used therapeutically, but as the main alkaloid extracted from papaver bracteatum (Iranian poppy), it can be converted industrially into a variety of compounds including oxycodone, oxymorphone, nalbuphine, naloxone, naltrexone, buprenorphine and etorphine.
Currently, because of the special properties of thebaine, subject to strict control in most countries, so the market production control by the countrys policy.
Thebaine production industry is a highly profitable industry. In the United States and other regions, more and more enterprises begin to apply to enter this field, but the current situation, the market is still controlled by the Mallinckrodt Pharmaceuticals and Noramco.
But as the downstream drugs market gradually matures, the next few years, thebaine and his relevant market will gradually popular, so the next few years, thebaine have a certain degree of price rise, but the rate should be minimal
The global Thebaine market was 1160 million US$ in 2020 and is expected to 1280 million US$ by the end of 2025, growing at a CAGR of 1.2% between 2020 and 2025.
The report forecast global Thebaine market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2020-2025.
First, this report covers the present status and the future prospects of the global Thebaine market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Mallinckrodt Pharmaceuticals
Noramco
Alcaliber
Tasmanian Alkaloids
TPI
Cepia-Sanofi
Taj Pharmaceuticals
API Labs
Faran Shimi Pharmaceuticals
Gansu Alkaloids
Hwells
By the product type, the market is primarily split into
Food Grade
Pharmaceutical Grade
By the end users/application, this report covers the following segments
Oxymorphone
Nalbuphine
Naltrexone
Buprenorphine
Others
At the same time, we classify Thebaine according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Thebaine market for the forecast period 2020 - 2025?
• What are the driving forces in the Thebaine market for the forecast period 2020 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Thebaine industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?